BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38530810)

  • 21. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas.
    Li J; Zhang Y; Qu Z; Ding R; Yin X
    Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G-protein Coupled Receptor 34 Promotes Gliomagenesis by Inducing Proliferation and Malignant Phenotype via TGF-Beta/Smad Signaling Pathway.
    Cheng Y; Heng X; Feng F
    Technol Cancer Res Treat; 2022; 21():15330338221105733. PubMed ID: 35770303
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients.
    Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J
    Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
    Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
    Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized risk stratification strategy for glioma patients based on the feature genes of poor immune cell infiltration patterns.
    Wan HT; Su ZJ; Guo ZS; Wen P; Hong XY
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13855-13874. PubMed ID: 37535161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.
    Mou Y; Zhang L; Liu Z; Song X
    BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the LINC00324/miR-16-5p/SEPT2 Signaling Cascade is Effective to Reverse Malignant Phenotypes in Glioblastoma.
    Chen B; Lin P; Li N
    Anticancer Agents Med Chem; 2023; 23(13):1535-1544. PubMed ID: 36852794
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Jiang W; Zheng F; Yao T; Gong F; Zheng W; Yao N
    Ann Transl Med; 2021 Nov; 9(22):1686. PubMed ID: 34988195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma.
    Xu Z; Xu H; Chen X; Huang X; Tian J; Zhao J; Liu B; Shi F; Wu J; Pu J
    Onco Targets Ther; 2023; 16():819-837. PubMed ID: 37873495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGFBP5, as a Prognostic Indicator Promotes Tumor Progression and Correlates with Immune Microenvironment in Glioma.
    Lin J; Huang G; Zeng Q; Zhang R; Lin Y; Li Y; Huang B; Pan H
    J Cancer; 2024; 15(1):232-250. PubMed ID: 38164271
    [No Abstract]   [Full Text] [Related]  

  • 32. Exploration of the radiosensitivity-related prognostic risk signature in patients with glioma: evidence from microarray data.
    Zhang X; Ren Q; Li Z; Xia X; Zhang W; Qin Y; Wu D; Ren C
    J Transl Med; 2023 Sep; 21(1):618. PubMed ID: 37700319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINC00324 promotes cell proliferation and metastasis of esophageal squamous cell carcinoma through sponging miR-493-5p via MAPK signaling pathway.
    Sharma U; Kaur Rana M; Singh K; Jain A
    Biochem Pharmacol; 2023 Jan; 207():115372. PubMed ID: 36493845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
    Liu J; Li G
    Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of overall survival-EMT-immune cell infiltration genes predict the prognosis of glioma.
    Zheng L; He JJ; Zhao KX; Pan YF; Liu WX
    Noncoding RNA Res; 2024 Jun; 9(2):407-420. PubMed ID: 38511063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of LINC00324 associated with methylation facilitates leukemogenesis in de novo acute myeloid leukemia.
    Sun GK; Xu ZJ; Nan FY; Tang LJ; Yao DM
    Int J Lab Hematol; 2022 Jun; 44(3):567-575. PubMed ID: 35218157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00324 affects non-small cell lung cancer cell proliferation and invasion through regulation of the miR-139-5p/IGF1R axis.
    Zhang M; Lin B; Liu Y; Huang T; Chen M; Lian D; Deng S; Zhuang C
    Mol Cell Biochem; 2020 Oct; 473(1-2):193-202. PubMed ID: 32734536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
    Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
    Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X
    Front Oncol; 2021; 11():682932. PubMed ID: 34123852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.